Ukrainian intelligence has identified at least 18 US citizens who signed contracts with the Russian army. Propaganda channels promise them significant financial payments, although some have already died on the battlefield.
Odoxa-Mascaret poll records historically lowest support for the French president, while National Rally leaders maintain 35% standing.
Fire Point co-founder Iryna Terekh registered the MILFtech trademark in her personal name, sparking a backlash. Meanwhile, Denys Shchiterman has again postponed the delivery of long-range weapons despite significant state funding.
Police and SBU exposed a 35-year-old Lviv resident who sold cocaine and MDMA. He faces up to 12 years in prison.
Following criticism of a June procurement that favoured a single brand, the DPA optimised technical conditions. This allowed it to order 130 units of equipment for UAH 61m less than in the previous tender.
Details of Leonid Titarenko's career, who is responsible for the security of the People's Deputy, include a criminal past, involvement in a shootout, and joint companies with the politician.
The musician is attempting to remove inconvenient publications from the internet by pressuring platforms to delete content through formal but false claims.
According to the Telegram channel Buddha from OP, Yulia Myronova started working at the Kyiv office of Maxi Group as a shift supervisor, a role involving the monitoring of call centre operators.
More than 28,000 people died while waiting for medical care in Canada in 2023–2024. This was reported by the SecondStreet agency.
The data indicates that 15,474 people died without receiving the necessary surgeries or diagnostic procedures. If regions that did not submit their data are taken into account, the actual number of deaths may be significantly higher, approaching 28,077.
In addition, the study shows that nearly 75,000 deaths among patients on waiting lists were recorded in Canada between 2018 and 2019, although the country's government does not officially publish this data.
Comments
No comments yet. Be the first!